Compounded Letrozole
About Letrozole
Compounded letrozole is a non-steroidal aromatase inhibitor used as adjuvant therapy for hormone-receptor-positive breast cancer in postmenopausal women, and off-label for ovulation induction in women with PCOS or unexplained infertility — where it has overtaken clomiphene as a preferred first-line agent. Commercial letrozole (Femara, generic) is available only as a 2.5 mg tablet, which is right for oncology dosing but limits fertility protocols that titrate 2.5–7.5 mg over a 5-day stimulation cycle and makes pediatric or dysphagia dosing difficult. Compounding pharmacies prepare letrozole in custom strengths, dye-free capsules, oral suspensions, and sublingual troches for patients with excipient sensitivities or alternative-route needs.
Who uses compounded letrozole
The largest clinical use of letrozole by volume is adjuvant therapy for hormone-receptor-positive early-stage breast cancer in postmenopausal women, at 2.5 mg daily for up to 5 years. It's also used in extended adjuvant therapy (after 5 years of tamoxifen) and for metastatic breast cancer.
Off-label, letrozole has become a first-line ovulation induction agent for women with PCOS and unexplained infertility. The PPCOS II trial (2014) showed letrozole produced higher live-birth rates than clomiphene citrate in PCOS-related anovulation, and most reproductive endocrinologists now use letrozole before or instead of clomiphene. Typical fertility dosing is 2.5–7.5 mg daily on cycle days 3–7, titrated based on ovarian response. Letrozole is also used in transgender fertility preservation and, rarely, in off-label TRT estradiol management (anastrozole is more commonly used for TRT because letrozole produces deeper estradiol suppression).
Why compound letrozole instead of using commercial tablets
Commercial letrozole comes only as a 2.5 mg tablet. For standard oncology dosing, that's the right strength — but three patient groups often need compounding.
First, fertility protocols that escalate from 2.5 mg to 5 mg to 7.5 mg daily can work with multiple commercial tablets, but some clinicians prefer single dose-appropriate capsules to improve adherence, and patients with sensitivities to the tablet's excipients (lactose, microcrystalline cellulose, magnesium stearate, titanium dioxide, hypromellose, talc, polyethylene glycol, yellow iron oxide in Femara 2.5 mg) need dye-free, filler-minimized capsules. Second, patients with dysphagia — including many oncology patients — need oral suspensions or troches. Third, rare pediatric off-label uses (e.g., constitutional delay of puberty protocols in adolescent males) require weight-based liquid dosing that the tablet can't provide.
Compounded letrozole in custom capsule strengths and oral suspensions solves each of these needs.
Typical letrozole dosing
Oncology dosing is 2.5 mg once daily, long-term. Letrozole is a reversible non-steroidal AI, so once-daily dosing maintains suppression of estrogen production.
Fertility dosing is typically 2.5 mg daily on cycle days 3–7 for a first cycle, escalating to 5 mg or 7.5 mg daily in subsequent cycles if ovulation is not achieved. Monitoring includes mid-luteal progesterone, follicular ultrasound, or both, depending on the protocol. Letrozole's short half-life (about 2 days) means it clears before embryo implantation — an advantage over clomiphene, which lingers longer.
Off-label TRT use is uncommon because letrozole typically over-suppresses estradiol — most TRT clinicians prefer anastrozole's gentler, more titratable profile. When letrozole is used in TRT, it's at very low fractional doses (e.g., 0.5–1 mg once weekly) that can't be reliably obtained from the 2.5 mg tablet.
Typical compounded letrozole pricing
Compounded letrozole capsules typically run $40–$85 for a 30-day supply at 2.5 mg, or $50–$110 at higher fertility strengths (5 mg, 7.5 mg). Oral suspensions are $55–$120 per 30-day supply. Sublingual troches are $50–$100.
Fertility-cycle supplies are often dispensed as a 5-day package rather than a 30-day supply, which varies the per-fill cost. Commercial generic letrozole 2.5 mg tablets are usually cheaper than compounding through insurance or discount programs. Compounding is the right choice when you need dye-free formulations, custom strengths, or an alternative route — not as a cost-saving measure for standard oncology dosing. Comparing quotes from multiple licensed compounding pharmacies typically saves 20–40%.
Typical Letrozole Pricing
Prices vary by dosage, formulation, quantity, and pharmacy. The range above reflects listings currently tracked by Compounding Finder and is not a guaranteed quote. Submit a request below to get a personalized quote for your specific needs.
How to Get Letrozole Quotes
Letrozole by State
Compare Letrozole prices from licensed compounding pharmacies in your state:
Why Compare Letrozole Prices?
Compounded medication prices vary significantly between pharmacies — sometimes by 300% or more for the exact same drug, strength, and formulation. Factors that affect pricing include the pharmacy’s location, their ingredient sourcing, and compounding volume.
By comparing quotes from multiple licensed pharmacies, you can find the best combination of price, quality, and convenience without spending hours making phone calls.
Frequently Asked Questions
Why is letrozole used for fertility if it's a breast cancer drug?
Letrozole briefly lowers estrogen production in the early follicular phase, which removes negative feedback on the pituitary and triggers a rise in FSH — stimulating ovarian follicle development and ovulation. Unlike clomiphene, letrozole has a short half-life and clears before implantation, which reduces the endometrial-thinning effects clomiphene can cause. The PPCOS II trial showed higher live-birth rates with letrozole than clomiphene in PCOS patients, and it is now a first-line option in most reproductive endocrinology practices. It is used off-label for fertility — not FDA-approved for this indication — but the evidence base is strong.
What is the difference between letrozole, anastrozole, and exemestane?
All three are aromatase inhibitors. Letrozole and anastrozole are non-steroidal and reversible — they bind aromatase transiently. Exemestane is steroidal and irreversible — it inactivates the enzyme permanently until new protein is synthesized. Clinically, all three are roughly equivalent as adjuvant breast cancer therapy, and practice guidelines let clinicians choose based on tolerability. Letrozole is the AI of choice for ovulation induction; anastrozole is the AI of choice for TRT estradiol management; exemestane is often used as switch therapy after tamoxifen or another AI.
Why would I need compounded letrozole instead of generic Femara?
Three main reasons: (1) you have a documented allergy or sensitivity to excipients in the commercial tablet (lactose, titanium dioxide, iron oxide dyes, polyethylene glycol) and need a dye-free, filler-minimized formulation; (2) you cannot swallow tablets and need a sublingual troche or oral suspension; or (3) your protocol calls for a strength (e.g., 5 mg or 7.5 mg single-dose capsules for fertility, or fractional doses) that the 2.5 mg tablet cannot deliver conveniently. Standard oncology dosing with no sensitivities is usually well-served by the commercial generic.
How much does compounded letrozole cost?
Compounded letrozole capsules typically run $40–$85 for a 30-day supply at 2.5 mg, or $50–$110 at higher fertility strengths (5 mg, 7.5 mg). Oral suspensions are $55–$120. Sublingual troches are $50–$100. Fertility protocols often use a 5-day cycle supply, which changes the per-fill cost. Commercial generic 2.5 mg tablets are typically cheaper through insurance for standard dosing; compounding pays for itself when you need custom strengths, dye-free formulations, or alternative delivery routes.
Get Free Quotes for Compounded Letrozole
Free quotes from licensed compounding pharmacies. No account, no obligation. Results in 1–2 business days.